Logo image of REAX

REAL BROKERAGE INC/THE (REAX) Stock Fundamental Analysis

NASDAQ:REAX - CA75585H2063 - Common Stock

5.38 USD
+0.16 (+3.07%)
Last: 8/29/2025, 8:00:01 PM
5.2624 USD
-0.12 (-2.19%)
After Hours: 8/29/2025, 8:00:01 PM
Fundamental Rating

4

REAX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. While REAX has a great health rating, there are worries on its profitability. REAX is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year REAX has reported negative net income.
REAX had a positive operating cash flow in the past year.
REAX had negative earnings in each of the past 5 years.
Of the past 5 years REAX 4 years had a positive operating cash flow.
REAX Yearly Net Income VS EBIT VS OCF VS FCFREAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

REAX has a worse Return On Assets (-8.52%) than 65.08% of its industry peers.
REAX's Return On Equity of -25.90% is on the low side compared to the rest of the industry. REAX is outperformed by 63.49% of its industry peers.
Industry RankSector Rank
ROA -8.52%
ROE -25.9%
ROIC N/A
ROA(3y)-40.4%
ROA(5y)-33.37%
ROE(3y)-84.35%
ROE(5y)-71.32%
ROIC(3y)N/A
ROIC(5y)N/A
REAX Yearly ROA, ROE, ROICREAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

REAX has a Gross Margin of 8.90%. This is in the lower half of the industry: REAX underperforms 68.25% of its industry peers.
In the last couple of years the Gross Margin of REAX has declined.
REAX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
REAX Yearly Profit, Operating, Gross MarginsREAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

7

2. Health

2.1 Basic Checks

REAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
REAX has more shares outstanding than it did 1 year ago.
REAX has more shares outstanding than it did 5 years ago.
There is no outstanding debt for REAX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
REAX Yearly Shares OutstandingREAX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
REAX Yearly Total Debt VS Total AssetsREAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

REAX has an Altman-Z score of 16.33. This indicates that REAX is financially healthy and has little risk of bankruptcy at the moment.
REAX has a Altman-Z score of 16.33. This is amongst the best in the industry. REAX outperforms 92.06% of its industry peers.
REAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 16.33
ROIC/WACCN/A
WACC8.87%
REAX Yearly LT Debt VS Equity VS FCFREAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.30 indicates that REAX should not have too much problems paying its short term obligations.
REAX has a Current ratio (1.30) which is in line with its industry peers.
A Quick Ratio of 1.30 indicates that REAX should not have too much problems paying its short term obligations.
REAX has a Quick ratio of 1.30. This is comparable to the rest of the industry: REAX outperforms 46.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.3
REAX Yearly Current Assets VS Current LiabilitesREAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 73.68% over the past year.
REAX shows a strong growth in Revenue. In the last year, the Revenue has grown by 72.60%.
The Revenue has been growing by 140.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)73.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)72.6%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%58.68%

3.2 Future

Based on estimates for the next years, REAX will show a very strong growth in Earnings Per Share. The EPS will grow by 42.18% on average per year.
The Revenue is expected to grow by 26.31% on average over the next years. This is a very strong growth
EPS Next Y74.5%
EPS Next 2Y39.48%
EPS Next 3Y42.18%
EPS Next 5YN/A
Revenue Next Year54.36%
Revenue Next 2Y35.41%
Revenue Next 3Y26.31%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
REAX Yearly Revenue VS EstimatesREAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
REAX Yearly EPS VS EstimatesREAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 -0.1 -0.15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for REAX. In the last year negative earnings were reported.
Also next year REAX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
REAX Price Earnings VS Forward Price EarningsREAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, REAX is valued cheaper than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.46
EV/EBITDA N/A
REAX Per share dataREAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

REAX's earnings are expected to grow with 42.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.48%
EPS Next 3Y42.18%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for REAX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REAL BROKERAGE INC/THE

NASDAQ:REAX (8/29/2025, 8:00:01 PM)

After market: 5.2624 -0.12 (-2.19%)

5.38

+0.16 (+3.07%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners43%
Inst Owner Change-0.35%
Ins Owners11.74%
Ins Owner ChangeN/A
Market Cap1.12B
Analysts86
Price Target6.46 (20.07%)
Short Float %1.5%
Short Ratio2.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)174.29%
Min EPS beat(2)56.43%
Max EPS beat(2)292.16%
EPS beat(4)4
Avg EPS beat(4)112.64%
Min EPS beat(4)34.64%
Max EPS beat(4)292.16%
EPS beat(8)6
Avg EPS beat(8)44.38%
EPS beat(12)8
Avg EPS beat(12)29.56%
EPS beat(16)11
Avg EPS beat(16)26.23%
Revenue beat(2)2
Avg Revenue beat(2)7.06%
Min Revenue beat(2)4.24%
Max Revenue beat(2)9.88%
Revenue beat(4)4
Avg Revenue beat(4)8.49%
Min Revenue beat(4)4.24%
Max Revenue beat(4)14.54%
Revenue beat(8)8
Avg Revenue beat(8)13.04%
Revenue beat(12)12
Avg Revenue beat(12)14.82%
Revenue beat(16)16
Avg Revenue beat(16)21.29%
PT rev (1m)0%
PT rev (3m)-5%
EPS NQ rev (1m)-300%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-75%
EPS NY rev (3m)51.72%
Revenue NQ rev (1m)3.58%
Revenue NQ rev (3m)15.11%
Revenue NY rev (1m)4.54%
Revenue NY rev (3m)5.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.69
P/FCF 16.46
P/OCF 16.23
P/B 22.85
P/tB 29.56
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.33
FCFY6.07%
OCF(TTM)0.33
OCFY6.16%
SpS7.77
BVpS0.24
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.52%
ROE -25.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.9%
FCFM 4.2%
ROA(3y)-40.4%
ROA(5y)-33.37%
ROE(3y)-84.35%
ROE(5y)-71.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
F-Score7
Asset Turnover10.86
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 65.56%
Cap/Sales 0.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 1.3
Altman-Z 16.33
F-Score7
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)186.01%
Cap/Depr(5y)132.24%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y74.5%
EPS Next 2Y39.48%
EPS Next 3Y42.18%
EPS Next 5YN/A
Revenue 1Y (TTM)72.6%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%58.68%
Revenue Next Year54.36%
Revenue Next 2Y35.41%
Revenue Next 3Y26.31%
Revenue Next 5YN/A
EBIT growth 1Y60.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year312.94%
EBIT Next 3Y83.62%
EBIT Next 5YN/A
FCF growth 1Y179.53%
FCF growth 3Y133.43%
FCF growth 5YN/A
OCF growth 1Y172.08%
OCF growth 3Y131.69%
OCF growth 5YN/A